PLoS ONE (Jan 2012)

Amyloid-beta (Aβ) D7H mutation increases oligomeric Aβ42 and alters properties of Aβ-zinc/copper assemblies.

  • Wei-Ting Chen,
  • Chen-Jee Hong,
  • Ya-Tzu Lin,
  • Wen-Han Chang,
  • He-Ting Huang,
  • Jhih-Ying Liao,
  • Yu-Jen Chang,
  • Yi-Fang Hsieh,
  • Chih-Ya Cheng,
  • Hsiu-Chih Liu,
  • Yun-Ru Chen,
  • Irene H Cheng

DOI
https://doi.org/10.1371/journal.pone.0035807
Journal volume & issue
Vol. 7, no. 4
p. e35807

Abstract

Read online

Amyloid precursor protein (APP) mutations associated with familial Alzheimer's disease (AD) usually lead to increases in amyloid β-protein (Aβ) levels or aggregation. Here, we identified a novel APP mutation, located within the Aβ sequence (Aβ(D7H)), in a Taiwanese family with early onset AD and explored the pathogenicity of this mutation. Cellular and biochemical analysis reveal that this mutation increased Aβ production, Aβ42/40 ratio and prolonged Aβ42 oligomer state with higher neurotoxicity. Because the D7H mutant Aβ has an additional metal ion-coordinating residue, histidine, we speculate that this mutation may promote susceptibility of Aβ to ion. When co-incubated with Zn(2+) or Cu(2+), Aβ(D7H) aggregated into low molecular weight oligomers. Together, the D7H mutation could contribute to AD pathology through a "double punch" effect on elevating both Aβ production and oligomerization. Although the pathogenic nature of this mutation needs further confirmation, our findings suggest that the Aβ N-terminal region potentially modulates APP processing and Aβ aggregation, and further provides a genetic indication of the importance of Zn(2+) and Cu(2+) in the etiology of AD.